Acute Heart Failure Clinical Trial
— ODINOfficial title:
Permanent Observatory of Heart Failure
NCT number | NCT01091441 |
Other study ID # | 06302 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | February 2007 |
Est. completion date | July 2014 |
Verified date | August 2019 |
Source | French Cardiology Society |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The observatory consists of a row of data collection on a population composed of all patients
with heart failure cared for in centers participating in the national education program for
patients (named I-CARE) in the form of two groups. Patients who are undergoing a program of
therapeutic education track are listed and included in the group of patients educated.
Patients who receive no education or only a minimal element for any reason whatsoever are
also listed and included in the group of patients who are not educated.
The following of patients will be periodic after their entry in the observatory, up to 2
years of follow up.
Status | Completed |
Enrollment | 3248 |
Est. completion date | July 2014 |
Est. primary completion date | July 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patient with heart failure - Patient supported by a center participating in the I-CARE french program Exclusion Criteria: - Refusal by the patient to be listed in an observatory |
Country | Name | City | State |
---|---|---|---|
France | Brabois-Nancy University Hospital | Vandoeuvre les Nancy |
Lead Sponsor | Collaborator |
---|---|
French Cardiology Society |
France,
Agrinier N, Schockmel M, Thilly N, Laborde-Castérot H, Jourdain P, Alla F, Leclercq C, Dany F, Druelle J, Drouet E, Mulak G, Juillière Y; ODIN cohort participants. Effectiveness of a patient education programme in heart failure with preserved ejection fra — View Citation
Garbacz L, Juillière Y, Alla F, Jourdain P, Guyon G, Coudane H, Hervé C, Claudot F. Perception of therapeutic patient education in heart failure by healthcare providers. Arch Cardiovasc Dis. 2015 Aug-Sep;108(8-9):446-52. doi: 10.1016/j.acvd.2015.03.008. E — View Citation
Juillière Y, Jourdain P, Suty-Selton C, Béard T, Berder V, Maître B, Trochu JN, Drouet E, Pace B, Mulak G, Danchin N; ODIN Cohort Participants. Therapeutic patient education and all-cause mortality in patients with chronic heart failure: a propensity anal — View Citation
Juillière Y, Suty-Selton C, Riant E, Darracq JP, Dellinger A, Labarre JP, Druelle J, Mulak G, Danchin N, Jourdain P; ODIN cohort participants. Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and ty — View Citation
Schockmel M, Agrinier N, Jourdain P, Alla F, Eicher JC, Coulon P, Druelle J, Mulak G, Danchin N, Thilly N, Juillière Y; ODIN cohort participants. Socioeconomic factors and mortality in diastolic heart failure. Eur J Clin Invest. 2014 Apr;44(4):372-83. doi — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Event-free survival | To analyse survival after 2 years of follow-up (all-causes death) | 2 years | |
Secondary | Recurrence of heart failure | Analyze the data of disease: recurrence of heart failure | 2 years | |
Secondary | Therapeutic | Analyze the data of disease: therapeutic took 2 years of follow-up | 2 years | |
Secondary | Number of participants with adverse events | Analyze the data of disease: cardiovascular events or other non-cardiovascular | 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02151383 -
Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure
|
Phase 2 | |
Completed |
NCT02135835 -
A Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure
|
Phase 4 | |
Recruiting |
NCT05556044 -
Empagliflozin for New On-set Heart Failure Study Regardless of Ejection Fraction
|
Phase 3 | |
Recruiting |
NCT04363697 -
Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)
|
Phase 4 | |
Completed |
NCT02122640 -
Evaluation of Acute Cardiogenic Dyspnoea With Thorax Echography and Pro-BNP in the Emergency Department
|
N/A | |
Not yet recruiting |
NCT01211886 -
Utility of Brain Natriuretic Peptide (BNP) in Patients With Type IV Cardio-renal Syndrome Admitted to the Intensive Care Unit (ICU)
|
N/A | |
Completed |
NCT01193998 -
Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department
|
N/A | |
Not yet recruiting |
NCT06465498 -
Investigating aCute heArt failuRe Decongestion Guided by Lung UltraSonography
|
N/A | |
Recruiting |
NCT05276219 -
Optimized Treatment of Pulmonary Edema or Congestion
|
Phase 4 | |
Recruiting |
NCT05392764 -
Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
|
Phase 3 | |
Recruiting |
NCT03157219 -
Manipal Heart Failure Registry (MHFR)
|
N/A | |
Completed |
NCT06024889 -
Acute Effects of Furosemide on Hemodynamics and Pulmonary Congestion in Acute Decompensated Heart Failure.
|
Phase 1/Phase 2 | |
Terminated |
NCT04174794 -
Investigating Reduction of aCute heArt Failure Readmission With Lung UltraSound-preliminary Trial
|
||
Recruiting |
NCT05972746 -
Telemonitoring Program in the Vulnerable Phase After Hospitalization for Heart Failure
|
N/A | |
Enrolling by invitation |
NCT02258984 -
Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial
|
N/A | |
Completed |
NCT02141607 -
Evolution of Molecular Biomarkers in Acute Heart Failure Induced by Shock
|
||
Completed |
NCT01870778 -
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
|
Phase 3 | |
Recruiting |
NCT05986773 -
Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic Resistance
|
Phase 4 | |
Recruiting |
NCT04163588 -
Sequential Nephron Blockade in Acute Heart Failure
|
Phase 3 | |
Recruiting |
NCT04329234 -
Korean Heart Failure Registry III
|